COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1834: Articles 18331-18340  | Next

Assessment of Post SARS CoV 2 Fatigue among Physicians Working in COVID Designated Hospitals in Dhaka, Bangladesh
Hasan, A. T. M. H., Islam, M. S., Khan, N., Munna, N. H., Choton, W. R., Arefin, M. K., Khan, M. A. A. Z., Mansur, M., Hassan, R., Siddiqui, N., Arefin, M. S., Afroje, N., Islam, M. S.
10.1101/2021.02.08.21251352 — Posted: 2021-02-10
Confirmed forecasts for the expansion of the COVID-19 epidemic in the S. Paulo city, Brazil
Celaschi, S.
10.1101/2021.02.08.21251290 — Posted: 2021-02-10
SARS-CoV-2 transmission, vaccination rate and the fate of resistant strains
Rella, S., Kulikova, Y., Dermitzakis, E., Kondrashov, F.
10.1101/2021.02.08.21251383 — Posted: 2021-02-10
Associations of DMT therapies with COVID-19 severity in multiple sclerosis
Simpson-Yap, S., De Brouwer, E., Kalincik, T., Rijke, N., Hillert, J., Walton, C., Edan, G., MOREAU, Y. Y., Spelman, T., Geys, L., Parciak, T., Gautrais, C., Lazovski, N., Pirmani, A., Ardeshirdavani, A., Forsberg, L., Glaser, A., McBurney, R., Schmidt, H., Bergmann, A., Braune, S., Stahmann, A., Middleton, R., Salter, A., Fox, R. J., van der Walt, A., Butzkueven, H., Al-Roughani, R., Ozakbas, S., Rojas, J. I., van der Mei, I., Nag, N., Ivanov, R., Sciascia do Olival, G., Estavo Dias, A., Magyari, M., Brum, D. G., Mendes, M. F., Alonso, R., Nicholas, R., Bauer, J., Chertcoff, A., Zabalza, A., Arrambide, G., Fidao, A., Comi, G., Peeters, L.
10.1101/2021.02.08.21251316 — Posted: 2021-02-10
Genomic surveillance of SARS-CoV-2 in the Bronx enables clinical and epidemiological inference
Fels, J. M., Khan, S., Forster, R., Skalina, K. A., Sirichand, S., Fox, A. S., Bergman, A., Mitchell, W. B., Wolgast, L. R., Szymczak, W. A., Bortz, R. H., Dieterle, M. E., Florez, C., Haslwanter, D., Jangra, R. K., Laudermilch, E., Wirchnianski, A. S., Barnhill, J., Goldman, D. L., Khine, H., Goldstein, D. Y., Daily, J. P., Chandran, K., Kelly, L.
10.1101/2021.02.08.21250641 — Posted: 2021-02-10
Expression of ACE2 receptor, soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin (1-7), is modulated in COVID-19 patients.
OSMAN, I. O., Menelotte, C., Brouqui, P., MILLION, M., LAGIER, J.-c., PAROLA, P., STEIN, A., LA SCOLA, B., MEDDEB, L., MEGE, J.-L., RAOULT, D., DEVAUX, C. A.
10.1101/2021.02.08.21251001 — Posted: 2021-02-10
Novel SARS-CoV-2 spike variant identified through viral genome sequencing of the pediatric Washington D.C. COVID-19 outbreak
LoTempio, J. E., Billings, E. A., Draper, K., Ralph, C., Moshgriz, M., Duong, N., Dien Bard, J., Gai, X., Wessel, D., DeBiasi, R. L., Campos, J. M., Vilain, E., Delaney, M., Michael, D. G.
10.1101/2021.02.08.21251344 — Posted: 2021-02-10 Discussion: Onsite
A Human 3D neural assembloid model for SARS-CoV-2 infection
Gleeson, J. G., Wang, L., Sievert, D., Clark, A. E., Federman, H., Gastfriend, B. D., Shusta, E., Palecek, S., Carlin, A., Clark, A. E.
10.1101/2021.02.09.430349 — Posted: 2021-02-09
Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
Bessiere, P., Wasniewsk, M., Picard-Meyer, E., Servat, A., Figueroa, T., Foret-Lucas, C., Coggon, A., Lesellier, S., Boue, F., Cebron, N., Gausseres, B., Trumel, C., Foucras, G., Salguero, F. J., Monchatre-Leroy, E., Volmer, R.
10.1101/2021.02.09.430458 — Posted: 2021-02-09
Disruption of nuclear architecture as a cause of COVID-19 induced anosmia
Zazhytska, M., Kodra, A., Hoagland, D. A., Fullard, J., Shayya, H. J., Omer, A., Firestein, S., Gong, Q., Canoll, P., Goldman, J. E., Roussos, P., tenOever, B. R., Overdevest, J. B., Lomvardas, S.
10.1101/2021.02.09.430314 — Posted: 2021-02-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).